Insulet Corporation Website

Insulet Corporation

NasdaqGS-PODD

Basic

  • Market Cap

    $13.37B

  • EV

    $14.02B

  • Shares Out

    70.04M

  • Revenue

    $1,780.7M

  • Employees

    3,000

Margins

  • Gross

    68.21%

  • EBITDA

    19.06%

  • Operating

    14.88%

  • Pre-Tax

    13.75%

  • Net

    13.14%

  • FCF

    8.18%

Returns (5Yr Avg)

  • ROA

    1.9%

  • ROTA

    9.43%

  • ROE

    8.26%

  • ROCE

    6.2%

  • ROIC

    8.31%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $233.64

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    $751.2M

  • Net Debt

    $650.3M

  • Debt/Equity

    1.77

  • EBIT/Interest

    7.07

Growth (CAGR)

  • Rev 3Yr

    22.92%

  • Rev 5Yr

    24.31%

  • Rev 10Yr

    21.27%

  • Dil EPS 3Yr

    196.55%

  • Dil EPS 5Yr

    71.19%

  • Dil EPS 10Yr

    16.14%

  • Rev Fwd 2Yr

    17.5%

  • EBITDA Fwd 2Yr

    22.81%

  • EPS Fwd 2Yr

    16.55%

  • EPS LT Growth Est

    28.44%

Dividends

  • Yield

    —

  • Payout

    —

  • DPS

    —

  • DPS Growth 3Yr

    —

  • DPS Growth 5Yr

    —

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    —

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Metric
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM

Total Revenues

738.2

904.4

1,098.8

1,305.3

1,697.1

1,780.7

Total Revenues % Chg.

30.9%

22.5%

21.5%

18.8%

30%

30.2%

Cost of Goods Sold, Total

257.9

322.1

346.7

441.8

548.7

566

Gross Profit

480.3

582.3

752.1

863.5

1,148.4

1,214.7

Selling General & Admin Expenses, Total

298

384

466

587.8

707.6

744.6

R&D Expenses

132.3

146.8

160.1

180.2

205

205.1

Other Operating Expenses, Total

430.3

530.8

626.1

768

912.6

949.7

Operating Income

50

51.5

126

95.5

235.8

265

Interest Expense, Total

-34.6

-48.1

-61.7

-36

-36.2

-37.5

Interest And Investment Income

—

6.9

3

0.5

9.3

28.6

31.5

Net Interest Expenses

-27.7

-45.1

-61.2

-26.7

-7.6

-6

Currency Exchange Gains (Loss)

—

—

—

—

-0.6

3.2

-2

-1.3

-0.4

-0.4

Other Non Operating Income (Expenses)

—

—

—

1.5

0.1

0.1

0.2

2.6

2.1

EBT, Excl. Unusual Items

23.2

9.7

62.9

67.7

230.4

260.7

Legal Settlements

—

—

—

—

—

—

—

—

—

-27.3

-27.3

Other Unusual Items

—

-8.7

—

-42.4

-57.9

11.5

11.5

EBT, Incl. Unusual Items

14.5

9.7

20.5

9.8

214.6

244.9

Income Tax Expense

2.9

2.9

3.7

5.2

8.3

10.9

Earnings From Continuing Operations

11.6

6.8

16.8

4.6

206.3

234

Earnings Of Discontinued Operations

—

—

—

—

—

—

—

—

Net Income

11.6

6.8

16.8

4.6

206.3

234

Net Income to Common Incl Extra Items

11.6

6.8

16.8

4.6

206.3

234

Net Income to Common Excl. Extra Items

11.6

6.8

16.8

4.6

206.3

234

Total Shares Outstanding

62.7

66

69.2

69.5

69.9

70

Weighted Avg. Shares Outstanding

60.6

64.7

67.7

69.4

69.8

69.8

Weighted Avg. Shares Outstanding Dil

62.3

65.9

68.6

69.9

73.6

74.5

EPS

0.2

0.1

0.2

0.1

3

3.4

EPS Diluted

0.2

0.1

0.2

0.1

2.9

3.3

EBITDA

77.9

106.9

183.4

158.7

308.6

339.4

Effective Tax Rate

20%

29.9%

18%

53.1%

3.9%

4.5%